Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Ottawa Heart Institute Research Corporation
Enrollment target
~24 participants
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2024